Korro Bio, Inc.
10-K
March 12, 2026
Key Highlights
- Successful merger with Legacy Korro, creating a focused genetic medicine company...
- Proprietary ADAR-mediated RNA editing platform offers precise *in vivo* gene cor...
- Lead program KORR-101 for Alpha-1 Antitrypsin Deficiency (AATD) completed precli...
Read Analysis
🤖 AI Generated